Can this form be e-signed?

Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states if you capture intent, consent, attribution, and a reproducible record.

Is PHI allowed in the approval?

PHI should only be included if necessary; use a HIPAA Business Associate Agreement and limit data to the minimum required to review clinical impact.

What authentication level is recommended?

Use at minimum email link plus identity verification for internal approvals; consider stronger multi-factor authentication for external or payer-facing approvals.

Do I need notarization or witnesses?

Most approvals do not need notarization; if the approval has legal effect on contracts or deeds, follow state rules for notarization and witness counts.

How do I correct a signed approval?

If minor, execute an amendment signed by the same approvers. For substantive changes, create a new approval referencing the original and retain both records.

How do I revoke an approval?

Revocation requires documented rescission signed by the same authority that approved the original or by an authorized successor per organizational policy.

Electronic Signature
Templates
Healthcare
Healthcare Drug Savings Project Approval

Healthcare Drug Savings Project Approval

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Drug Savings Project Approval

This Healthcare Drug Savings Project Approval documents patient enrollment and authorization to participate in a program designed to reduce out-of-pocket prescription drug costs through coordination with payors, pharmacies, and manufacturer savings programs. Patient Name: Patient ID Number:

Patient Information

Full Legal Name

Date of Birth

Gender Male Female Other Prefer not to say

Address

Phone

Email

Emergency Contact

Insurance Information

Primary Insurance Provider

Policy Number

Group Number

Subscriber Name

Medical History (Relevant)

Current Medications Allergies No known drug allergies Prior Surgeries / Significant Conditions

Project Details and Financial Estimate

Project Title Project Sponsor / Coordinator

Proposed Start Date

Proposed End Date

Project Summary Primary Objectives Anticipated Patient Savings (average per month)

Authorization and Consent

By signing below, Patient Name: authorizes the program sponsor and its authorized agents to: (1) access and use protected health information (PHI) necessary to determine eligibility and implement drug savings interventions; (2) disclose PHI to payors, pharmacies, and manufacturer assistance programs solely to secure financial assistance and optimize coverage for prescription medications; and (3) communicate with the patient via telephone, secure electronic messaging, or mail for program administration.

This authorization is limited to information reasonably necessary to verify insurance, evaluate benefit alternatives, submit prior authorizations or appeals, and process patient assistance applications. The patient understands that participation is voluntary and that refusal to sign will not affect access to standard medical treatment. The patient further acknowledges that any savings are estimates and not guaranteed.

Authorization Expiration Date Acknowledgements I understand I may revoke this authorization at any time in writing, except to the extent the program has acted in reliance on this authorization. I acknowledge the program does not guarantee enrollment outcomes or specific dollar savings. I permit the program to coordinate directly with my insurer and pharmacy regarding benefits, prior authorizations, and copay assistance.

HIPAA / Privacy Acknowledgment

I acknowledge that I have been provided with or offered a copy of the entity's Notice of Privacy Practices describing how my protected health information may be used and disclosed in connection with this program and my care. I understand that information disclosed under this authorization may be redisclosed by the recipient and may no longer be protected under privacy laws.

I acknowledge receipt of the Notice of Privacy Practices and consent to the uses and disclosures described above.

Administrative Review (Program Use)

Reviewed By (Name) Title Review Date

Administrative approval indicates that the program coordinator has reviewed the information provided, verified insurance and eligibility to the extent possible, and authorized program enrollment steps to be initiated. Administrative fields above are for internal use and do not substitute for patient consent.

Data Use and Security

The program will use administrative, clinical, and claims data only as necessary to perform the functions described herein. The program will maintain reasonable administrative, technical, and physical safeguards to protect electronic and paper records in accordance with applicable privacy and security standards.

Patient Printed Name:

Signature:

Relationship (if not patient):

Date:

What the Healthcare Drug Savings Project Approval Is

The Healthcare Drug Savings Project Approval is an internal approval form used by healthcare organizations and sponsors to authorize planned cost-reduction projects for prescription drugs and related supply chain changes. It documents the project scope, estimated savings, affected drug list, clinical and pharmacy leadership approvals, funding source, and implementation timeline. The form serves as a single record for compliance review, budget control, and audit purposes, and it can be adapted to vendor procurement, formulary changes, or payer-negotiation workflows while preserving required signatures and approval authorities.

Why this approval matters for healthcare programs

A documented approval aligns clinical, pharmacy, finance, and legal stakeholders before changes are implemented. It creates traceable authorization for cost-saving measures and supports internal audits and external reporting while reducing downstream compliance risk.

Who typically completes and signs this approval

Teams that coordinate clinical and financial decisions complete the form so implementation is consistent with policy.

Pharmacy leadership and formulary committees responsible for drug selection and clinical oversight.
Finance or contracting staff who validate projected savings and funding sources.
Legal or compliance teams who confirm regulatory and payer implications before execution.

Use role-based signoff to ensure the approval reflects multi-department agreement and creates an auditable trail.

Signatory roles and typical submitters

Pharmacy Director

A Pharmacy Director or Chief Pharmacy Officer usually reviews clinical impact, endorses formulary changes, and provides the primary clinical signature. They confirm that substitutions or procurement strategies maintain standard of care and patient safety.

Finance Officer

A Finance Officer or Director of Contracting verifies the savings calculation, available budget, and payment terms. Their approval ensures projected cost reductions are realistic and that accounting entries reflect program changes.

Step-by-step: completing the approval form

Complete fields in logical order to avoid rework and missing approvals.

01

1. Prepare: Gather drug lists, contracts, and savings analysis.
02

2. Draft: Populate scope, timelines, and methodology sections.
03

3. Review: Circulate to pharmacy, finance, and legal for comments.
04

4. Sign: Collect required signatures and record the effective date.

Typical routing and approval flow

Approvals move through functional owners in a defined sequence to ensure accountability and compliance.

Initiator: Prepares the request and supporting analysis.
Pharmacy Review: Assesses clinical appropriateness and patient impact.
Finance Review: Validates savings and budget alignment.
Final Authorization: Authorized official signs and records the decision.

Configuring an electronic approval workflow

Configure routing, authentication, and retention settings to match your organization’s controls.

Field	Configuration
Routing Order	Sequential or parallel signer flow
Authentication	Email link, SMS code, or stronger MFA
Notifications	Auto-reminders and escalation rules
Retention	Set record retention per policy

Technical requirements for digital completion and signing

Use a secure eSignature platform that supports audit trails and necessary compliance controls.

Document Formats: PDF, DOCX supported
Integrations: EHR, ERP, storage connectors
Authentication: Email or MFA options

Ensure the platform supports HIPAA BAAs if PHI is included, archive export formats, and a verifiable audit trail for each signed approval.

Required data elements for the approval

Project Title: Full descriptive name

Sponsor: Legal entity name

Drug Identifiers: Generic name, strength, NDC

Savings Estimate: Dollar amount and method

Approval Dates: Effective and signature dates

Approver Names: Title and printed name

Key risks and consequences of incorrect approvals

HIPAA Exposure: Civil/ criminal penalties for PHI mishandling (45 CFR §160–164)

Contract Breach: Vendor penalties or indemnity obligations

Financial Misstatement: Incorrect savings affect budgets and audits

Regulatory Noncompliance: Potential penalties from payers or regulators

Delayed Implementation: Lost savings and operational disruption

Audit Findings: Increased oversight and remediation costs

Common mistakes to avoid when preparing an approval

Submitting incomplete drug identifiers (omitting strength or NDC) causes procurement delays and can lead to incorrect orders or supply chain errors.
Using vague savings estimates without methodology makes forecasts unverifiable in audits and reduces confidence from finance and contracting teams.
Failing to obtain role-based signoffs or routing out of order increases legal and compliance exposure and complicates retrospective reviews.
Including protected health information without a signed HIPAA BAA or encryption may trigger breach reporting obligations and regulatory penalties.

eSignature vendor pricing and capability snapshot

Compare typical starting price and core capabilities relevant to healthcare approval workflows. Confirm plan details with each vendor for features like HIPAA BAAs and envelope limits.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Plan-dependent	Plan-dependent	Plan-dependent	Plan-dependent
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about approvals and e-signing

Answers to common questions about completing, signing, and storing the Healthcare Drug Savings Project Approval.

Need help? Contact support

Can this form be e-signed?
Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states if you capture intent, consent, attribution, and a reproducible record.
Is PHI allowed in the approval?
PHI should only be included if necessary; use a HIPAA Business Associate Agreement and limit data to the minimum required to review clinical impact.
What authentication level is recommended?
Use at minimum email link plus identity verification for internal approvals; consider stronger multi-factor authentication for external or payer-facing approvals.
Do I need notarization or witnesses?
Most approvals do not need notarization; if the approval has legal effect on contracts or deeds, follow state rules for notarization and witness counts.
How do I correct a signed approval?
If minor, execute an amendment signed by the same approvers. For substantive changes, create a new approval referencing the original and retain both records.
How do I revoke an approval?
Revocation requires documented rescission signed by the same authority that approved the original or by an authorized successor per organizational policy.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now